| Date Filed | Type | Description |
| 06/12/2023 |
4
| Wolterman Dan (Director) has filed a Form 4 on NUVASIVE INC|
Txns:
| Granted 4,816 options to buy
@ $0 |
|
| 06/12/2023 |
4
| Raimundo Amy Belt (Director) has filed a Form 4 on NUVASIVE INC|
Txns:
| Granted 4,816 options to buy
@ $0 |
|
| 06/12/2023 |
4
| Norwalk Leslie V (Director) has filed a Form 4 on NUVASIVE INC|
Txns:
| Granted 4,816 options to buy
@ $0 |
|
| 06/12/2023 |
4
| Kadia Siddhartha (Director) has filed a Form 4 on NUVASIVE INC|
Txns:
| Granted 4,816 options to buy
@ $0 |
|
| 06/12/2023 |
4
| Huennekens R Scott (Director) has filed a Form 4 on NUVASIVE INC|
Txns:
| Granted 4,816 options to buy
@ $0 |
|
| 06/12/2023 |
4
| FRIEL ROBERT F (Director) has filed a Form 4 on NUVASIVE INC|
Txns:
| Granted 4,816 options to buy
@ $0 |
|
| 06/12/2023 |
4
| DeFord John A (Director) has filed a Form 4 on NUVASIVE INC|
Txns:
| Granted 4,816 options to buy
@ $0 |
|
| 06/12/2023 |
4
| CAPPS VICKIE L (Director) has filed a Form 4 on NUVASIVE INC|
Txns:
| Granted 4,816 options to buy
@ $0 |
|
| 01/03/2023 |
4
| Harbaugh Matthew K (EVP and CFO) has filed a Form 4 on NUVASIVE INC|
Txns:
| Paid exercise price by delivering 440 shares
@ $41.24, valued at
$18.1k
Exercised 1,286 options to buy
@ $0 |
|
| 09/08/2022 |
3
| Farrington Michael (SVP, People and Culture) has filed a Form 3 on NUVASIVE INC |
| 06/01/2022 |
4
| Norwalk Leslie V (Director) has filed a Form 4 on NUVASIVE INC|
Txns:
| Exercised 1,547 options to buy
@ $0 |
|
| 06/01/2022 |
4
| Kadia Siddhartha (Director) has filed a Form 4 on NUVASIVE INC|
Txns:
| Exercised 1,037 options to buy
@ $0
Exercised 2,702 options to buy
@ $0 |
|
| 05/23/2022 |
3/A
| NUVASIVE INC (10% Owner) has filed a Form 3/A on Aclarion, Inc. |
| 05/19/2022 |
3
| Rosenbaum Marc W. (Chief Accounting Officer) has filed a Form 3 on NUVASIVE INC |
| 05/13/2022 |
4
| Rosenberg Donald J (Director) has filed a Form 4 on NUVASIVE INC|
Txns:
| Exercised 13,326 shares
@ $0
Exercised 2,822 options to buy
@ $0
Exercised 2,130 options to buy
@ $0
Exercised 2,577 options to buy
@ $0
Exercised 3,095 options to buy
@ $0
Exercised 2,702 options to buy
@ $0 |
|
| 05/13/2022 |
4
| Wolterman Dan (Director) has filed a Form 4 on NUVASIVE INC|
Txns:
| Granted 3,788 options to buy
@ $0 |
|
| 05/13/2022 |
4
| Raimundo Amy Belt (Director) has filed a Form 4 on NUVASIVE INC|
Txns:
| Granted 3,788 options to buy
@ $0 |
|
| 05/13/2022 |
4
| Norwalk Leslie V (Director) has filed a Form 4 on NUVASIVE INC|
Txns:
| Granted 3,788 options to buy
@ $0 |
|
| 05/13/2022 |
4
| Kadia Siddhartha (Director) has filed a Form 4 on NUVASIVE INC|
Txns:
| Granted 3,788 options to buy
@ $0 |
|
| 05/13/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/13/2022 |
4
| FRIEL ROBERT F (Director) has filed a Form 4 on NUVASIVE INC|
Txns:
| Granted 3,788 options to buy
@ $0 |
|
| 05/13/2022 |
4
| DeFord John A (Director) has filed a Form 4 on NUVASIVE INC|
Txns:
| Granted 3,788 options to buy
@ $0 |
|
| 05/13/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/22/2022 |
3
| NUVASIVE INC (10% Owner) has filed a Form 3 on Aclarion, Inc. |
| 04/15/2022 |
4
| Barry James Christopher (CEO) has filed a Form 4 on NUVASIVE INC|
Txns:
| Sold 5,000 shares
@ $58, valued at
$290k
|
|
| 03/30/2022 |
4
| Barry James Christopher (CEO) has filed a Form 4 on NUVASIVE INC|
Txns:
| Sold 5,000 shares
@ $55, valued at
$275k
|
|
| 03/03/2022 |
4
| Wolf Dale A. (SVP, Global Operations) has filed a Form 4 on NUVASIVE INC|
Txns:
| Paid exercise price by delivering 1,239 shares
@ $54.51, valued at
$67.5k
Exercised 1,450 options to buy
@ $0
Exercised 2,565 options to buy
@ $0
Granted 6,421 options to buy
@ $0 |
|
| 03/03/2022 |
4
| Morton Andrew C. (SVP, CHRO) has filed a Form 4 on NUVASIVE INC|
Txns:
| Granted 6,421 options to buy
@ $0 |
|
| 03/03/2022 |
4
| SISITSKY NATHANIEL (SVP & General Counsel) has filed a Form 4 on NUVASIVE INC|
Txns:
| Paid exercise price by delivering 2,868 shares
@ $54.51, valued at
$156.3k
Exercised 2,899 options to buy
@ $0
Exercised 5,130 options to buy
@ $0
Granted 6,421 options to buy
@ $0 |
|
| 03/03/2022 |
4
| Harbaugh Matthew K (EVP and CFO) has filed a Form 4 on NUVASIVE INC|
Txns:
| Granted 14,677 options to buy
@ $0 |
|
| 03/03/2022 |
4
| Calafiore Massimo (EVP, Chief Commercial Officer) has filed a Form 4 on NUVASIVE INC|
Txns:
| Paid exercise price by delivering 3,088 shares
@ $54.51, valued at
$168.3k
Exercised 3,141 options to buy
@ $0
Exercised 5,558 options to buy
@ $0
Granted 11,008 options to buy
@ $0 |
|
| 03/03/2022 |
4
| Barry James Christopher (CEO) has filed a Form 4 on NUVASIVE INC|
Txns:
| Paid exercise price by delivering 20,792 shares
@ $54.51, valued at
$1.1M
Exercised 19,323 options to buy
@ $0
Exercised 34,200 options to buy
@ $0
Granted 45,864 options to buy
@ $0 |
|
| 02/14/2022 |
3
| Morton Andrew C. (SVP, CHRO) has filed a Form 3 on NUVASIVE INC |
| 02/14/2022 |
4
| Wolf Dale A. (SVP, Global Operations) has filed a Form 4 on NUVASIVE INC|
Txns:
| Granted 1,450 options to buy
@ $0 |
|
|